ASC Theraputics Revenue and Competitors
Estimated Revenue & Valuation
- ASC Theraputics's estimated annual revenue is currently $3.6M per year.
- ASC Theraputics's estimated revenue per employee is $155,000
Employee Data
- ASC Theraputics has 23 Employees.
- ASC Theraputics grew their employee count by -18% last year.
ASC Theraputics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Gene and Cell Therapy | Reveal Email/Phone |
2 | SVP, Global Operations | Reveal Email/Phone |
3 | Senior Director Quality | Reveal Email/Phone |
4 | Scientist and Senior Lab Manager | Reveal Email/Phone |
5 | Executive Assistant and HR Manager | Reveal Email/Phone |
6 | Principle Scientist | Reveal Email/Phone |
7 | Senior Scientist | Reveal Email/Phone |
ASC Theraputics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is ASC Theraputics?
ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities. #therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia www.asctherapeutics.com
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ASC Theraputics News
Most recently, ASC Therapeutics received Fast Track Designation from the U.S. Food and Drug Administration for its therapy for hemophilia A,...
ASC Therapeutics is a biopharmaceutical company pioneering the development of gene replacement therapies, in-vivo gene editing and allogeneic...
... include Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, ... Essential Hemophilia A Pipeline therapies such as SPK-8011,...
Other Companies in Milpitas
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 23 | 44% | N/A |
#2 | $4.2M | 24 | 4% | N/A |
#3 | $2.4M | 24 | -17% | N/A |
#4 | $9.5M | 25 | 56% | $35M |
#5 | $4.8M | 25 | -7% | N/A |